1. Home
  2. ENTA vs SRTA Comparison

ENTA vs SRTA Comparison

Compare ENTA & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.23

Market Cap

374.6M

Sector

Health Care

ML Signal

HOLD

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$4.48

Market Cap

388.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTA
SRTA
Founded
1995
2014
Country
United States
United States
Employees
N/A
601
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
374.6M
388.1M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ENTA
SRTA
Price
$14.23
$4.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$20.40
$7.81
AVG Volume (30 Days)
110.5K
649.7K
Earning Date
05-11-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
N/A
EPS
N/A
N/A
Revenue
$102,814,000.00
N/A
Revenue This Year
$7.76
$39.27
Revenue Next Year
N/A
$9.09
P/E Ratio
N/A
$9.88
Revenue Growth
16.48
N/A
52 Week Low
$4.96
$3.85
52 Week High
$17.15
$6.02

Technical Indicators

Market Signals
Indicator
ENTA
SRTA
Relative Strength Index (RSI) 57.65 55.91
Support Level $13.39 $4.23
Resistance Level $15.52 $4.69
Average True Range (ATR) 0.75 0.16
MACD 0.20 0.05
Stochastic Oscillator 75.80 89.57

Price Performance

Historical Comparison
ENTA
SRTA

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

Share on Social Networks: